Observational studyInternational journal of laboratory hematology2026
Rapid Fibrinogen Assessment With the qLabs FIB Point-of-Care System: Results From a Multicenter Clinical Validation Study.
Observational study in International journal of laboratory hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcquired hypofibrinogenemia is frequently associated with major bleeding and requires prompt correction. Rapid and accurate quantification of fibrinogen is essential to guide hemostatic therapy and improve patient outcomes. The qLabs FIB system provides fibrinogen results within minutes at the bedside, supporting timely diagnostic assessment and therapeutic decision-making. This study aimed to validate the device analytical performance in a prospective, observational, multicenter setting by comparing whole-blood qLabs FIB results with lab-based plasma fibrinogen.
methodsFibrinogen concentrations from 463 citrated whole-blood samples were measured in parallel using the qLabs FIB and the Clauss method across 8 clinical sites.
resultsOverall, a strong correlation was observed between the qLabs FIB and the Clauss laboratory method (r = 0.94). The median of relative differences did not differ significantly between clinical sites. Receiver operating characteristic analysis showed sensitivities and specificities in the 90% range for identifying fibrinogen concentrations below the clinical decision thresholds of 1.5 and 2.0 g/L.
conclusionThis study demonstrated a strong agreement of the qLabs FIB to the standard Clauss assay while providing rapid, near-patient fibrinogen measurements. This multicenter study confirms the initial performance of the system from a larger number of samples. The integration of qLabs FIB testing into routine clinical practice could support earlier, more targeted hemostatic interventions, thereby improving the safety and effectiveness of bleeding management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.